Insights into Mechanisms of Amyloid Toxicity:  Molecular Dynamics Simulations of the Amyloid andbeta-peptide (Aandbeta) and Islet Amyloid Polypeptide (IAPP)

dc.contributor.authorBrown, Anne M.en
dc.contributor.committeechairBevan, David R.en
dc.contributor.committeememberSchubot, Florian D.en
dc.contributor.committeememberWhite, Robert H.en
dc.contributor.committeememberXu, Binen
dc.contributor.departmentBiochemistryen
dc.date.accessioned2016-12-21T07:01:03Zen
dc.date.available2016-12-21T07:01:03Zen
dc.date.issued2016-04-07en
dc.description.abstractAggregation of proteins into amyloid deposits is a common feature among dozens of diseases. Two such diseases that feature amyloid deposits are Alzheimer's disease (AD) and type 2 diabetes (T2D). AD toxicity has been associated with the aggregation and accumulation of the amyloid β-peptide (Aβ); Aβ exerts its toxic effects through interactions with neuronal cell membranes. A characteristic feature of T2D is the deposition of the islet amyloid polypeptide (IAPP) in the pancreatic islets of Langerhans. It is currently unknown if IAPP aggregation is a cause or consequence of T2D, but it does lead to β-cell dysfunction and death, exacerbating the effects of diabetes. Characterizing the fundamental interactions between both Aβ and IAPP with lipid membranes and in solution will give greater insight into mechanisms of toxicity exhibited by amyloid proteins. In this work, molecular dynamics (MD) simulations were used to study the secondary, tertiary, and quatnary structure of Aβ and IAPP, in addition to peptide-membrane interactions and membrane perturbation as independently caused by both peptides. Studies were conducted to address the following questions: (1) what influence do solution conditions and oxidation state have on monomeric Aβ] (2) how and in what way does monomeric Aβ interact with model lipid membranes and what role does sequence play on these peptide-membrane interactions; (3) can MD simulations be utilized to understand Aβ tetramer formation, rearrangement, and tetramer-membrane interactions; (4) how does IAP interact with model membranes and how does that vary from non-toxic (rat) IAPP peptide-membrane interactions. These studies led to conclusions that showed variance in lipid affinity and degree of perturbation as based on peptide sequence, in addition to insight into the type of perturbation caused to membranes by these amyloid peptides. Understanding the differences in peptide-membrane interactions of amyloidogenic and non-amyloidogenic (rat) peptides gave insight into the overall mechanism of amyloidogenicity, leading to the detection of specific amino acids essential in peptide-membrane perturbation. These residues can then be targeted for novel therapeutic design to attenuate the perturbation and potential cell death as caused by these peptides.en
dc.description.degreePh. D.en
dc.format.mediumETDen
dc.identifier.othervt_gsexam:7310en
dc.identifier.urihttp://hdl.handle.net/10919/73773en
dc.publisherVirginia Techen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectamyloid proteinsen
dc.subjectamyloiden
dc.subjectislet amyloid polypeptide (IAPP)en
dc.subjectpeptide-membrane interactionsen
dc.subjectmolecular dynamics simulationsen
dc.titleInsights into Mechanisms of Amyloid Toxicity:  Molecular Dynamics Simulations of the Amyloid andbeta-peptide (Aandbeta) and Islet Amyloid Polypeptide (IAPP)en
dc.typeDissertationen
thesis.degree.disciplineBiochemistryen
thesis.degree.grantorVirginia Polytechnic Institute and State Universityen
thesis.degree.leveldoctoralen
thesis.degree.namePh. D.en

Files

Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Brown_AM_D_2016.pdf
Size:
61.64 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Brown_AM_D_2016_support_1.pdf
Size:
380.88 KB
Format:
Adobe Portable Document Format
Description:
Supporting documents